Toll-like receptor 2 signalling and inflammation.
Liew
F Y
FY
Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow G11 6NT, UK. f.y.liew@clinmed.gla.ac.uk
Patel
M
M
Xu
D
D
D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001426:Bacterial Proteins / Q000627:therapeutic use*; D004195:Disease Models, Animal; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000276:immunology; D018664:Interleukin-12 / Q000096:biosynthesis; D008074:Lipoproteins / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D051195:Toll-Like Receptor 2 / Q000819:agonists* / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000276:immunology
D001426:Bacterial Proteins; D008074:Lipoproteins; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; D016212:Transforming Growth Factor beta; D016753:Interleukin-10; D018664:Interleukin-12; D007371:Interferon-gamma